SJP-L-5 is a inhibitor of HIV-1 infection by blocking viral DNA nuclear entry. References: Zhang XJ, Wang RR, Chen H, Luo RH, Yang LM, Liu JP, Sun HD, Zhang HB, Xiao WL, Zheng YT. SJP-L-5 inhibits HIV-1 polypurine tract primed plus-strand DNA elongation, indicating viral DNA synthesis initiation at multiple sites under drug pressure. Sci Rep. 2018 Feb 7;8(1):2574. doi: 10.1038/s41598-018-20954-5. PubMed PMID: 29416083; PubMed Central PMCID: PMC5803243.

纯度：≥98%

CAS：1286237-83-9